Compare BioNano Genomics Inc (BNGO) vs FirstEnergy Corp. (FE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BioNano Genomics Inc vs FirstEnergy Corp. — how do they compare? BioNano Genomics Inc trades at $1.17 (market cap $13.20M), while FirstEnergy Corp. trades at $48.95 (market cap $28.01B). The key difference: FirstEnergy Corp. is far larger — about 2122× BioNano Genomics Inc's market cap, and FirstEnergy Corp. pays a 3.84% dividend while BioNano Genomics Inc pays none. Which is the better fit depends on your goals.
| BNGO | FE | |
|---|---|---|
Market Cap | $13.20M | $28.01B |
Sector | Health | Utilities |
52-Week High | $4.92 | $51.91 |
52-Week Low | $1.09 | $40.30 |
Enterprise Value | $15.81M | $56.02B |
Dividend Yield | — | 3.84% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Bionano Genomics (BNGO) trades at $1.17, down 2.5% today, but maintains a bullish technical signal with strong moving average support. The company shows improving fundamentals with revenue stabilizing around $29M annually and narrowing losses, though it remains unprofitable with a -109.95% net margin. Recent positive developments include debt retirement and growing adoption of optical genome mapping technology.
BNGO presents a high-risk, high-reward opportunity with analyst consensus leaning bullish (57% buy ratings). The stock trades at attractive valuation multiples (P/S 0.31, P/B 0.36) but faces execution risks in achieving profitability. Key catalysts include continued technology adoption and potential margin improvement, while persistent losses and competitive pressures remain concerns.
FirstEnergy Corp. (FE) trades at $48.43, up 1.06% on the day, with a bullish technical signal supported by moving averages. The stock shows steady revenue growth, reaching $15.09B in 2025, and maintains a net income margin of 6.86%. Analyst consensus is a Buy with a $52.00 price target, reflecting optimism around grid investments and data center demand. Recent news highlights FE's strategic positioning amid rising energy needs and infrastructure upgrades.
Outlook is positive due to strong fundamentals and growth initiatives, but risks include high debt levels and regulatory pressures. The stock offers potential upside from current levels, supported by earnings beats and institutional confidence, though investors should monitor cash flow trends and execution of capital expenditures.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BioNano Genomics Inc
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.
Read more on BNGO →About FirstEnergy Corp.
FirstEnergy is one of the largest investor-owned utilities in the United States with 10 regulated distribution companies across six mid-Atlantic and Midwestern states. FirstEnergy also owns and operates one of the nation's largest electric transmission systems with 24,000 miles of lines.
Read more on FE →
